Pacira Pharmaceuticals Raises $85 Million in Series A

Pacira Pharmaceuticals, a San Diego based maker of controlled-release injectable products, has expanded its Series A round to $85 million. It had previously secured approximately $30 million. Backers include MPM Capital, HBM BioVentures, OrbiMed Advisors and Sanderling Ventures.

$85M is quite a haul but Pacira isn’t your normal, early stage delivery company. They already have an approved and marketable product in DepoFoam, a delivery technology that provides sustained-release delivery of injectable medications (e.g.; biologics).

Pacira has created formulations for six of the current top selling biologics; including EPO, G-CSF, hGH, INF-, FSH, and one undisclosed drug and intends to develop one or more of these assets as part of a biosimilar/bioimprovement strategy.

It seems this company is poised for a win. With the huge biosimilar push from insurers and a method for improved biologics dosing from companies, they have the market covered from both sides.

Pacira Pharmaceuticals, Inc. Raises $85 Million
-(Via BioSpace.com Featured News and Stories.)

Theoretically Related Posts

• October 30, 2008 -- Alnara Pharmaceuticals, Inc. Secures $20 Million in Series A Round (0)
• July 7, 2008 -- Secretive Agios Makes Splash with $33M Series A (0)
• April 16, 2009 -- Lycera Closes $36 Million Series A (0)
• February 24, 2009 -- Heptares Secures $30M in Series A Funding (0)
• December 4, 2008 -- Catalyst Biosciences Raises $40 Million in Series C Financing (1)
• November 17, 2008 -- Zafgen Raises $14 Million in Series B (0)
• October 28, 2008 -- Lutonix Inc. Announces $20 Million Series B Financing (0)
• October 22, 2008 -- Apitope Raises EUR 10 Million in Series A Financing (0)
• August 25, 2008 -- Proteostasis Rakes in $45M in Series A (0)
• June 23, 2008 -- Immune Design Nets $18M in Series A (0)

This post was constructed by

Eben Tessari

.

Eben is a highly caffeinated business development associate at a small, cash sensitive pharmaceutical company somewhere in Massachusetts. He enjoys cliche-less banter, compartmentalization, non-equilibrium thermodynamics and NPV analysis. Agree or disagree with what he's posted? He encourages comments.

If one were so inclined, one could follow him at any of these fine web 2.0 establishments:


Feel free to leave a comment below. Eben loves comments. You may also subscribe to comments through this RSS Comments feed or trackback here.

Add New Comment

Subscribe:  This Thread

Go to:  My Comments ·  Community Page

Sort thread by: Hot comments Best comments Newest first Oldest first

Viewing 1 Comment

Thanks. Your comment is awaiting approval by a moderator.

Do you already have an account? Log in and claim this comment.

• 
  • 
  • 
  

  • Permalink
  • Admin
  • • Remove Post
    • Block username
    • Block email
    • Block IP address

  HGH 5 months ago 1 point

  Please login to rate.

  Do you already have an account? Log in and claim this comment.

  Pacira is really going very strong. $85 million is a huge amount. Health industry is always green , even in recession time
  reply  edit   record video comment  reblog  flag
  1 /people/HGH/ /people/HGH/following/ http://www.alwaysbuyhgh.com

 

Add New Comment

Trackbacks

(Trackback URL)